PRRT2 and Hyperglycemia: When DM is not well treated, chronic hyperglycaemia ensues, and this leads to a variety of metabolic changes, such as the accumulation of advanced glycation end products (AGE), increased polyol pathway flux, reactive oxygen species (ROS) production, as well as activation of protein kinase C (PKC) pathway.